PHOENIX, AZ / ACCESSWIRE / February 9, 2023 / As Super Bowl LVII approaches, with the American Football Conference champion Kansas City Chiefs and the National Football Conference champion ...
- Enhanced Brain Function Assessment System Objectively Evaluates Cognitive Brain Function in Minutes at the Point of Care - BOSTON, MA / ACCESSWIRE / August 2, 2022 / NeuroCatch Inc. ("NCI"), a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Canadian brain health ...
Surrey, B.C. and Calgary, A.B. (August 20, 2019) - NeuroCatch Inc., a brain-focused health technology company committed to translating research innovations into real-world medical devices and ...
NeuroCatch Inc., a brain-focused health technology company committed to translating research innovations into real-world medical devices and applications, is pleased to announce a research ...
PHOENIX — A Canadian medical company, NeuroCatch, Inc., opened its U.S. headquarters in Phoenix on Oct. 1 as a participant of the Arizona State University and Mayo Clinic MedTech Accelerator program, ...
Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada A wholly owned subsidiary of HealthTech Connex, ...
The NeuroCatch Platform is a 6-Minute Brain Function Assessment System Licensed by Health Canada as a Class II Medical Device VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) -- KetamineOne ...
VANCOUVER, BC, Nov. 28, 2024 /PRNewswire/ - NeuroCatch is proud to announce its integration into a new cognitive performance program for elite athletes: Elevate by NeuroCatch. This program is designed ...
SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc. has received a Health Canada medical device licence for Canada's first and only objective, rapid neuro-physiological brain function assessment system ...
Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc.